These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1439128)

  • 21. Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.
    DePaz RA; Henderson I; Advant SJ
    Vaccine; 2005 Jul; 23(31):4029-35. PubMed ID: 15963360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice.
    Caulfield MJ; Shi L; Wang S; Wang B; Tobery TW; Mach H; Ahl PL; Cannon JL; Cook JC; Heinrichs JH; Sitrin RD
    Hum Vaccin; 2007; 3(4):139-45. PubMed ID: 17581283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant synergy in the response to hepatitis B vaccines.
    Wang S; Liu X; Caulfield MJ
    Vaccine; 2003 Oct; 21(27-30):4297-306. PubMed ID: 14505912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1.
    Hamilton JA; Byrne R; Whitty G
    J Leukoc Biol; 2000 Feb; 67(2):226-32. PubMed ID: 10670584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant.
    Levesque PM; de Alwis U
    Hum Vaccin; 2005; 1(2):70-3. PubMed ID: 17038824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of aluminum-induced inhibition of the intestinal absorption of calcium in the pathogenesis of aluminum osteopathy].
    Blahos J; Care AD; Abbas M; Aaron J; Porsova I
    Ann Endocrinol (Paris); 1989; 50(1):40-3. PubMed ID: 2729880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The formation of concretions of aluminum salts of fatty acids after the use of aluminum hydroxide.
    CHILD GP; HALL WK; AUERBACH SH
    Am J Dig Dis; 1947 Feb; 14(2):63. PubMed ID: 20286588
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of aluminium phosphate on antibody response to killed poliomyelitis vaccne.
    BUTLER NR; WILSON BD; BENSON PF; DUDGEON JA; UNGAR J; BEALE AJ
    Lancet; 1962 Jul; 2(7247):114-5. PubMed ID: 13875201
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo absorption of aluminium-containing vaccine adjuvants using 26Al.
    Flarend RE; Hem SL; White JL; Elmore D; Suckow MA; Rudy AC; Dandashli EA
    Vaccine; 1997; 15(12-13):1314-8. PubMed ID: 9302736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
    Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Al adjuvants can be tracked in viable cells by lumogallion staining.
    Mile I; Svensson A; Darabi A; Mold M; Siesjö P; Eriksson H
    J Immunol Methods; 2015 Jul; 422():87-94. PubMed ID: 25896212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations.
    Mold M; Shardlow E; Exley C
    Sci Rep; 2016 Aug; 6():31578. PubMed ID: 27515230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel identified aluminum hydroxide-induced pathways prove monocyte activation and pro-inflammatory preparedness.
    Kooijman S; Brummelman J; van Els CACM; Marino F; Heck AJR; Mommen GPM; Metz B; Kersten GFA; Pennings JLA; Meiring HD
    J Proteomics; 2018 Mar; 175():144-155. PubMed ID: 29317357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of adjuvant effect of A1PO4 on purified influenza virus hemagglutinins in man.
    Davenport FM; Hennessy AV; Askin FB
    J Immunol; 1968 May; 100(5):1139-40. PubMed ID: 5648476
    [No Abstract]   [Full Text] [Related]  

  • 35. Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis.
    Amini Y; Moradi B; Fasihi-Ramandi M
    Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1331-1335. PubMed ID: 27647321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of surface charge in the optimization of antigen-adjuvant interactions.
    Callahan PM; Shorter AL; Hem SL
    Pharm Res; 1991 Jul; 8(7):851-8. PubMed ID: 1924135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adsorption studies of aureomycin hydrochloride on aluminum hydroxide gel.
    DI GANGI FE; ROGERS CH
    J Am Pharm Assoc Am Pharm Assoc; 1949 Dec; 38(12):646. PubMed ID: 15398560
    [No Abstract]   [Full Text] [Related]  

  • 38. Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants.
    Ljutic B; Ochs M; Messham B; Ming M; Dookie A; Harper K; Ausar SF
    Vaccine; 2012 Apr; 30(19):2981-8. PubMed ID: 22381074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Critical analysis of reference studies on aluminium-based adjuvants toxicokinetics].
    Masson JD; Crépeaux G; Authier FJ; Exley C; Gherardi RK
    Ann Pharm Fr; 2017 Jul; 75(4):245-256. PubMed ID: 28576261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium phosphate: a substitute for aluminum adjuvants?
    Masson JD; Thibaudon M; Bélec L; Crépeaux G
    Expert Rev Vaccines; 2017 Mar; 16(3):289-299. PubMed ID: 27690701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.